CEMZY Fair Value & Analysis
Consumer Defensive · Market cap 29.1B TRY
Fair value as of: Aug 6, 2026
From 13 valuation models · updated today
Share price −6.7% over the past month.
Below-average quality, and screening another 84% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (3.21 TRY). The favourable scenario is already priced in.
- Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (1.37 TRY to 3.21 TRY) leaves room in how you read the outcome.
Price vs Fair Value (23 months)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 6, 2026.
How to read this chart
23‑month range 1.66 TRY – 1,000,000 TRY · fair‑value band 1.37 TRY – 3.21 TRY · the 12.60 TRY price screens above the 2.07 TRY fair value. Dashed = 300-day average. As of Aug 6, 2026.
Analysis
CEMZY (CEMZY) currently trades at 12.60 TRY, while our model-based Fair Value estimate is 2.07 TRY, implying the stock looks roughly 83.6% overvalued today. We read business quality at 41/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, CEMZY generated revenue of 2.7B TRY at a net margin of -4.9%. Revenue declined 9.7% year over year. It earns a return on equity of -3.3%. Net debt stands at 651M TRY. Fundamentals as of Aug 6, 2026
Our scenario range runs from 1.37 TRY (bear case) to 3.21 TRY (bull case); at 12.60 TRY, the current price sits above that range. For context, the median of 10 Consumer Defensive peers we cover trades at 102% fair-value upside, at -84%, CEMZY screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: Multiples (3.73 TRY) versus Asset-Based (1.14 TRY). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 6, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 45 · Market factors (momentum, volatility) 43
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
CEMZY reported revenue of 2.8B TRY in FY2025 versus 1.5B TRY in FY2022, a compound +24.0%/yr. Reported net income was −497M TRY in FY2025.
CEMZY screens 84% overvalued. Compare with Archer-Daniels-Midland Company →
Peer Group
Farm Products · 294 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Farm Products median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Aug 6, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Archer-Daniels-Midland Company ADM | $82.30 | $38.02 | -54% |
| Muyuan Foods Group 002714 | ¥40.90 | ¥48.19 | +18% |
| Wens Foodstuff Group 300498 | ¥14.51 | ¥12.08 | -17% |
| Mowi ASA MOWI | kr 188.40 | kr 262.59 | +39% |
| Charoen Pokphand Foods Public Company CPF | 22.00 THB | 55.71 THB | +153% |
| PT Charoen Pokphand Indonesia Tbk, CPIN | 3,120 IDR | 7,076 IDR | +127% |
| PT Triputra Agro Persada Tbk TAPG | 1,540 IDR | 3,105 IDR | +102% |
| PT FAP Agri Tbk FAPA | 7,300 IDR | 7,463 IDR | +2% |
| PT Japfa Comfeed Indonesia Tbk JPFA | 2,070 IDR | 7,231 IDR | +249% |
| Thaifoods Group TFGR | 10.60 THB | 23.53 THB | +122% |
Compare CEMZY with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is CEMZY overvalued or undervalued?
What is the fair value of CEMZY?
What is the quality score of CEMZY?
What is the revenue of CEMZY?
What is the net profit margin of CEMZY?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track CEMZY and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.